Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 2,000 | 0 | 1,340 | 2,703 | 904 |
| Cost of Goods | 1,987 | N/A | N/A | N/A | N/A |
| Gross Profit | 13 | N/A | 1,340 | 2,703 | 904 |
| Operating Expenses | 16,088 | 12,781 | 17,109 | 43,301 | 13,230 |
| Operating Income | -15,088 | -12,781 | -15,769 | -40,598 | -12,326 |
| Interest Expense | 0 | 853 | 2,037 | 0 | 87 |
| Other Income | 90,412 | -2,286 | 22,894 | 2,934 | 158 |
| Pre-tax Income | 75,324 | -15,920 | 5,088 | -37,664 | -12,255 |
| Income Tax | 11,308 | 3,183 | N/A | 100 | N/A |
| Net Income Continuous | 64,016 | -19,103 | 5,088 | -37,764 | -12,255 |
| Minority Interests | -34 | -43 | -437 | -1,203 | -587 |
| Net Income | $64,050 | $-19,060 | $5,525 | $-36,561 | $-11,668 |
| EPS Basic Total Ops | 1.53 | -0.48 | 0.14 | -0.94 | -0.31 |
| EPS Basic Continuous Ops | 1.55 | -0.47 | 0.13 | -0.97 | -0.33 |
| EPS Diluted Total Ops | 1.40 | -0.48 | 0.14 | -0.94 | -0.31 |
| EPS Diluted Continuous Ops | 1.51 | -0.47 | 0.13 | -0.97 | -0.33 |
| EPS Diluted Before Non-Recurring Items | 0.07 | -0.48 | -0.27 | -0.94 | -0.78 |
| EBITDA(a) | $-14,967 | $-12,588 | $-15,573 | $-40,540 | $-12,308 |